Fig. 3From: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinomaThe association between HSD17B6 expression and survival rates of HCC patients. a–d Kaplan–Meier analysis of OS (Overall survival), PFS (Progression-free survival), RFS (Relapse-free survival) and DSS (Disease specific survival) in the TCGA-LIHC patients based on HSD17B6 expression. e, f Kaplan–Meier analysis of OS (Overall survival) in the patients with HCC based on HSD17B6 expression of GSE14520 and ICGC-LIRI-JP datasets using HCCDBBack to article page